Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BRD7-IN-1, a modified derivative of BI7273 (BRD7/9 inhibitor), forms PROTAC VZ185 through linkage to a VHL ligand, demonstrating potent activity against BRD7/9 with DC50 values of 4.5 and 1.8 nM, respectively [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 179.00 | |
5 mg | In stock | $ 455.00 | |
10 mg | In stock | $ 690.00 | |
25 mg | In stock | $ 1,320.00 | |
50 mg | In stock | $ 1,830.00 | |
100 mg | In stock | $ 2,470.00 |
Description | BRD7-IN-1, a modified derivative of BI7273 (BRD7/9 inhibitor), forms PROTAC VZ185 through linkage to a VHL ligand, demonstrating potent activity against BRD7/9 with DC50 values of 4.5 and 1.8 nM, respectively [1]. |
Molecular Weight | 467.39 |
Formula | C22H28Cl2N4O3 |
CAS No. | 2448414-48-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 30 mg/mL (64.19 mM), Sonication is recommended.
H2O: 100 mg/mL (213.95 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BRD7-IN-1 2448414-48-8 Chromatin/Epigenetic Epigenetic Reader Domain Inhibitor BRD7IN1 BRD7 IN 1 BRD-7-IN-1 inhibit inhibitor